Adirondack Trust CO Novartis Ag Transaction History
Adirondack Trust CO
- $259 Million
- Q4 2024
A detailed history of Adirondack Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Adirondack Trust CO holds 228 shares of NVS stock, worth $24,361. This represents 0.01% of its overall portfolio holdings.
Number of Shares
228
Previous 289
21.11%
Holding current value
$24,361
Previous $33,000
33.33%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,439Shares Held
135MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.18 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$865 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$746 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$616 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...